Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 112, Issue 13, 4895-4904, December 15, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Interleukin-1–mediated hematopoietic cell regulation in the aorta-gonad-mesonephros region of the mouse embryo
Blood Orelio et al. 112: 4895

Supplemental materials for: Orelio et al

Files in this Data Supplement:

  • Table S1. RT-PCR primer sequences (PDF, 65 KB)

  • Figure S1. Control optimization experiments examining the effects of IL-1β stimulation on 3T3 fibroblast cells (JPG, 48.8 KB) -
    (A) 3T3 fibroblasts were stimulated with IL-1β (10 ng/ml) for 0 min, 30 min or 2 hrs and RNA was isolated and used for cDNA synthesis. Serial dilutions of the cDNA were used for semi-quantitative RT-PCR and analysis was performed with Typhoon and ImageQuant software. IL-1β stimulation of 3T3 fibroblasts results in increased expression of the IL-1β target gene Junb as determined by semi-quantitative RT-PCR. (B) Fold induction of Junb expression induced by IL-1β stimulation in 3T3 cells. Results calculated from RT-PCR values. (C) Schematic presentation of the RT-PCR results (fold induction) show that IL-1β induced Junb gene induction in 3T3 fibroblasts can be blocked with an IL-1β blocking antibody (Ab) and that cyclohexamide (CHX) does not interfere with the induction of the immediate early Junb target gene. Cells were pre-treated with cyclohexamide (Sigma) at a final concentration of 10µg/ml for 1 hr prior to IL-1β stimulation. For blocking IL-1β, 2000 fold excess (200ng) IL-1 blocking antibody (R&D systems) was incubated with IL-1β (100 pg) for 2 hours on ice prior to addition to the cells.





  • Figure S2. Engraftment of transplanted Il1r1−/− E11 AGM cells is multilineage (JPG, 40.9 KB) -
    Representative semi-quantitative PCR analysis at four months post-transplantation for (A) multilineage hematopoietic repopulation of a recipient transplanted with Il1rI−/− E11 AGM explant cells and (B) peripheral blood DNA of six secondary transplantation recipients that received bone marrow from (A). Percentage donor marker contributions (Neo gene of the Il1rI−/− locus) are indicated below each lane. Controls include the Myo gene DNA normalization and quantatitation standards containing 100, 60, 30, 10, 6, 1 and 0% donor (Neo) DNA. BL=blood; BM=bone marrow; E=erythroid; L=lymphoid; M=myeloid; Spl-spleen; T=T lymphocyte; B=B lymphocyte; Thy=thymus; LN=lymph node.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020